368 related articles for article (PubMed ID: 32302264)
21. Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer center.
Dashevsky BZ; Gallagher KM; Grabenstetter A; Cordeiro PG; Dogan A; Morris EA; Horwitz SM; Sutton EJ
Breast J; 2019 Jan; 25(1):69-74. PubMed ID: 30521149
[TBL] [Abstract][Full Text] [Related]
22. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
[TBL] [Abstract][Full Text] [Related]
23. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients.
Adrada BE; Miranda RN; Rauch GM; Arribas E; Kanagal-Shamanna R; Clemens MW; Fanale M; Haideri N; Mustafa E; Larrinaga J; Reisman NR; Jaso J; You MJ; Young KH; Medeiros LJ; Yang W
Breast Cancer Res Treat; 2014 Aug; 147(1):1-14. PubMed ID: 25073777
[TBL] [Abstract][Full Text] [Related]
24. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
25. Implant deformity on screening mammography, an unusual presentation of breast implant associated lymphoma.
Thambavitage W; Budhavaram V; Dessauvagie B; Rijhumal A; Gunawardena D; Taylor DB
Clin Imaging; 2022 Feb; 82():83-87. PubMed ID: 34798563
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2020 Aug; 44(4):1109-1115. PubMed ID: 32766915
[TBL] [Abstract][Full Text] [Related]
27. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
28. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity.
Xu J; Wei S
Arch Pathol Lab Med; 2014 Jun; 138(6):842-6. PubMed ID: 24878027
[TBL] [Abstract][Full Text] [Related]
29. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
30. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract][Full Text] [Related]
31. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)].
Hedén P; Stark B
Lakartidningen; 2018 Jun; 115():. PubMed ID: 29917175
[TBL] [Abstract][Full Text] [Related]
32. How I treat breast implant-associated anaplastic large cell lymphoma.
Mehta-Shah N; Clemens MW; Horwitz SM
Blood; 2018 Nov; 132(18):1889-1898. PubMed ID: 30209119
[TBL] [Abstract][Full Text] [Related]
33. How to Diagnose and Treat Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Clemens MW; Brody GS; Mahabir RC; Miranda RN
Plast Reconstr Surg; 2018 Apr; 141(4):586e-599e. PubMed ID: 29595739
[TBL] [Abstract][Full Text] [Related]
34. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
35. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
36. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
[TBL] [Abstract][Full Text] [Related]
37. Breast-implant-associated anaplastic large-cell lymphoma.
Ozalla Samaniego S; Meijide Santos G; Soto Dopazo M; Baldó Sierra C
Radiologia (Engl Ed); 2022 Mar; 64 Suppl 1():44-48. PubMed ID: 35428467
[TBL] [Abstract][Full Text] [Related]
38. PET-CT for the staging of breast implant- -associated anaplastic large cell lymphoma.
Siminiak N; Czepczyński R
Nucl Med Rev Cent East Eur; 2019; 22(2):90-91. PubMed ID: 31482564
[No Abstract] [Full Text] [Related]
39. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
40. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Kadin ME
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
